Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Biotechnology Animations – Biotechnology Illustrations

Clinical Animations / Trial Animations

Clinical Studies Animated Method of Action Video

Medical Animation Studio produces clinical animations and clinical illustrations.  Custom 3d trail illustrations and clinical illustrations for e learning can also be produced.   Biotechnology animations and biotechnology illustrations created for biotech companies and biotechnology marketing companies.
Biotechnology animated method of action video. 
Dr Nano
Investigational biologic cleared skin better, faster and for longer than ustekinumab in Phase II psoriasis study
New results from a Phase II head-to-head psoriasis study showed superior efficacy of Boehringer Ingelheim's investigational biologic compound BI 655066*, over ustekinumab.
Long-term efficacy of Gilenya reinforced by new 'no evidence of disease activity' (NEDA-4) analysis in MS patients over seven years
Novartis has announced a new analysis from the phase III FREEDOMS and FREEDOMS II trials reinforcing the long-term efficacy profile of Gilenya® (fingolimod).
New data presented from large studies consolidating the effectiveness, safety and tolerability of Sativex in patients with spasticity symptoms in MS
Almirall, the global pharmaceutical company based in Barcelona, presented new clinical evidences of Sativex®, the only medicine derived from cannabinoids to treat spasticity symptoms in MS...
Bavarian Nordic announces initiation of safety and immunogenicity study of Ebola vaccine regimen in Sierra Leone
Bavarian Nordic A/S has announced the initiation of a new clinical study of the Ebola prime-boost vaccine regimen that combines Bavarian Nordic's MVA-BN® Filo vaccine with the Ad26. launches Metastatic Trial Search (BCT) has teamed up with five breast cancer advocacy organizations to make finding out about clinical trial options for metastatic breast cancer easier, faster, and more...
New data show strong, sustained effects of TECFIDERA (dimethyl fumarate) in newly-diagnosed and early disease course multiple sclerosis patients
Biogen presented new data that reinforce the proven efficacy and well-established safety profile of TECFIDERA® (dimethyl fumarate) in a broad range of people with relapsing-remitting multiple...
Multiple sclerosis: Results from ZINBRYTA Phase 3 DECIDE study highlighting efficacy compared to Interferon Beta-1a published
Full results from the Phase 3 DECIDE study published this week in the New England Journal of Medicine (NEJM), as well as new post-hoc analyses of Phase 3 clinical data presented at an international...
Treatment for rare bleeding disorder effective and well-tolerated, studies show
Two international studies show eltrombopag is an effective and well-tolerated treatment for children with persistent or chronic immune thrombocytopenia, a rare bleeding disorder.
'Blind analysis' could reduce bias in social science, biology research
Other disciplines should borrow technique from the physical sciencesA course on critical thinking at the University of California, Berkeley, co-taught for the past three years by a public policy...
Epilepsy: Vimpat EU positive monotherapy Phase 3 results
UCB has announced positive results of a Phase 3 non-inferiority study designed to compare efficacy and safety of lacosamide to carbamazepine-CR (controlled release; retard tablets) as monotherapy...
Treatment effects maintained over five years in majority of patients with relapsing remitting MS who received Lemtrada in clinical trials
Sanofi and its subsidiary Genzyme has announced positive new five-year investigational data from the extension study of Lemtrada® (alemtuzumab) for patients with relapsing remitting multiple...
Magee clinical trial opens to examine therapies on invasive lobular breast cancer
Physicians at Magee-Womens Hospital of UPMC and the University of Pittsburgh Cancer Institute (UPCI) have opened a clinical trial to learn more about how three commonly prescribed anti-estrogen...
Developing a gel that mimics human breast for cancer research to reduce the need for animal models
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research...
New analysis suggests Aubagio (teriflunomide) slows brain atrophy in people with relapsing multiple sclerosis
Sanofi and its subsidiary Genzyme announced that magnetic resonance imaging (MRI) data from the Phase III TEMSO study demonstrate that Aubagio® (teriflunomide) significantly slowed brain volume...
Ocrelizumab first investigational medicine to show efficacy in people with primary progressive multiple sclerosis in large Phase III study
Genentech, a member of the Roche Group, has announced positive results from a pivotal Phase III study that evaluated the investigational medicine ocrelizumab in people with primary progressive...
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2015
Content Management / Website Design by Tresware